Birth Control Pills May Offer Protection Against COVID-19

woman holding birth control pack

Patcharin Simalhek / EyeEm / Getty Images

Key Takeaways

  • Estrogen can enhance the effects of the immune system.
  • Women who take the birth control pill may be less likely to develop severe COVID-19.
  • Post-menopausal women showed higher predicted rates of COVID-19 and hospitalization.

New research has found that estrogen-containing birth control may help lower infection rates and reduce the severity of symptoms in women who are infected with COVID-19. Specifically, researches found women who take the combined oral contraceptive pill (COCP)—which contains both estrogen and progesterone—had fewer positive cases and fewer hospitalizations.

The study, published ahead of print by King's College London, relied on data from nearly 600,000 UK women entered into the COVID Symptom Study App during May and June. Because estrogen, a sex hormone, has been shown to boost the immune system's response to viral infection, the researchers anticipated the protective effect of estrogen-containing birth control.

"For patients in whom combined oral contraceptive use is appropriate, these findings have the potential to influence decision-making when choosing a birth control method given this possible added non-contraceptive benefit," Adrienne Davis, APRN, WHNP-BC, a board-certified women's health nurse practitioner based in Georgia, tells Verywell. Davis was not involved in the King's College study. "Further evaluation of how estrogen may magnify [immune system] effects could be very promising in terms of prevention of COVID-19 and reduction in the severity of symptoms."

What This Means For You

Taking birth control pills does not mean you are immune to COVID-19. Your risk of developing severe COVID-19 may be slightly reduced, according to this study, but it's important to continue protective measures like mask-wearing and social distancing. Always consult with your healthcare provider before starting, stopping, or changing any medication regimen, such as birth control.

Estrogen and COVID-19

To get a broad look at the link between estrogen levels and COVID-19, researchers segmented data into three groups:

  1. Pre-menopausal women using the COCP form of birth control
  2. Post-menopausal women
  3. Post-menopausal women taking hormone replacement therapy (HRT)

Researchers then compared the 295,689 study participants taking the birth control pill to a control group of 231,436 women of the same age and body mass index not taking any form of birth control or hormonal therapy. While this age range of 18 to 45 included post-menopausal women, 85% were pre-menopausal.

Women using the pill had a lower rate of predicted COVID-19, a lower hospitalization rate, and a reduced frequency of symptoms, including:

  • Persistent cough
  • Delirium
  • Loss of smell
  • Severe fatigue 
  • Loss of appetite
  • Pain

Post-menopausal women ages 40 to 60 who were not on any form of birth control or hormone therapy had higher rates of predicted COVID-19 than other women, and slightly higher rates of hospitalization. Researchers say this is because estrogen levels decline after menopause.

Interestingly, post-menopausal women ages 50 to 65 taking hormone replacement therapy—which often includes estrogen—did not show the same lower predicted COVID-19 rates as younger women taking the pill. However, the COVID Symptom Study App included little information regarding HRT type, route of administration, and treatment duration, so the information may be incomplete.

More Research Is Needed

It is important to note that this study is a preprint. This means it has not been peer-reviewed and evaluated and should not be used for clinical guidance.

Not all experts are convinced estrogen is protective against the pandemic.

"I do not believe there is enough information to make the claim that estrogen exposure reduces the rate of COVID-19 or the severity of its symptoms," Dedra Sally, MSN, WHNP-BC, CNM, a board-certified women's health nurse practitioner and certified nurse midwife based in North Carolina, tells Verywell.

Above all, Sally says the younger age of the pre-menopausal women taking the COCP explains their lower COVID-19 risk more than estrogen can, at least when compared to post-menopausal women.

"Women on combined oral contraceptives tend to be younger and in the pre-menopausal state," she says. "It's possible that post-menopausal women are more susceptible to COVID-19 due to age-related factors and comorbidities rather than having less estrogen exposure."

The information in this article is current as of the date listed, which means newer information may be available when you read this. For the most recent updates on COVID-19, visit our coronavirus news page.

Was this page helpful?
2 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Costeira R, Lee KA, Murray B, Christiansen C, et al. Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study [epub ahead of print]. medRxiv. August 2, 2020. doi:10.1101/2020.07.30.20164921

  2. Taneja V. Sex hormones determine immune response. Front Immunol. 2018;9:1931. doi:10.3389/fimmu.2018.01931